Literature DB >> 26526831

Ceramide: Therapeutic Potential in Combination Therapy for Cancer Treatment.

Feifei Li, Na Zhang1.   

Abstract

Combination therapy has become an important strategy for treating cancer in recent years. Ceramide, which is a powerful tumor suppressor, regulating the processes of cell proliferation, differentiation, senescence and apoptosis, has attracted tremendous attention in combination therapy for cancer treatment. It has been demonstrated that combination of chemotherapeutic drugs and ceramide led to a reversion of multidrug resistance (MDR), synergistic tumor inhibition while simultaneously reducing systemic toxicity in cancer treatment. In this review, we aim to reveal the interactions between some anticancer drugs and ceramide, and summarize the research progress in combination therapies based on ceramide. Synthesis, metabolism and anticancer mechanisms of ceramide were described. Furthermore, the advantages of combination of chemotherapeutic drugs and exogenous ceramide, cerami-degenerating agents or modulators of ceramide metabolism were highlighted. Future perspective and problems to solve before the extension of ceramide's applications were also discussed. It is hoped that this review will provide new ideas for combination therapies in cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26526831     DOI: 10.2174/1389200216666151103120338

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN: 1389-2002            Impact factor:   3.731


  19 in total

Review 1.  Novel Sphingolipid-Based Cancer Therapeutics in the Personalized Medicine Era.

Authors:  Jeremy Shaw; Pedro Costa-Pinheiro; Logan Patterson; Kelly Drews; Sarah Spiegel; Mark Kester
Journal:  Adv Cancer Res       Date:  2018-06-19       Impact factor: 6.242

2.  The sphingosine kinase 2 inhibitor ABC294640 displays anti-non-small cell lung cancer activities in vitro and in vivo.

Authors:  Lu Dai; Charles D Smith; Maryam Foroozesh; Lucio Miele; Zhiqiang Qin
Journal:  Int J Cancer       Date:  2018-01-04       Impact factor: 7.396

Review 3.  The role of dihydrosphingolipids in disease.

Authors:  Ruth R Magaye; Feby Savira; Yue Hua; Darren J Kelly; Christopher Reid; Bernard Flynn; Danny Liew; Bing H Wang
Journal:  Cell Mol Life Sci       Date:  2018-12-06       Impact factor: 9.261

4.  Developing new ceramide analogs and identifying novel sphingolipid-controlled genes against a virus-associated lymphoma.

Authors:  Jungang Chen; Navneet Goyal; Lu Dai; Zhen Lin; Luis Del Valle; Jovanny Zabaleta; Jiawang Liu; Steven R Post; Maryam Foroozesh; Zhiqiang Qin
Journal:  Blood       Date:  2020-11-05       Impact factor: 22.113

5.  Lipidome signatures of metastasis in a transgenic mouse model of sonic hedgehog medulloblastoma.

Authors:  Danning Huang; Jingbo Liu; Ronald C Eldridge; David A Gaul; Martin R L Paine; Karan Uppal; Tobey J MacDonald; Facundo M Fernández
Journal:  Anal Bioanal Chem       Date:  2020-08-14       Impact factor: 4.142

6.  Novel glucosylceramide synthase inhibitor based prodrug copolymer micelles for delivery of anticancer agents.

Authors:  Jieni Xu; Whenchen Zhao; Jingjing Sun; Yixian Huang; Pengcheng Wang; Raman Venkataramanan; Da Yang; Xiaochao Ma; Ajay Rana; Song Li
Journal:  J Control Release       Date:  2018-09-14       Impact factor: 9.776

7.  Ceramide lipid-based nanosuspension for enhanced delivery of docetaxel with synergistic antitumor efficiency.

Authors:  Tianqi Wang; Lixia Feng; Shaomei Yang; Yongjun Liu; Na Zhang
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

8.  MiR-124 acts as a tumor suppressor by inhibiting the expression of sphingosine kinase 1 and its downstream signaling in head and neck squamous cell carcinoma.

Authors:  Yuan Zhao; Zhiqiang Ling; Yubin Hao; Xiaowu Pang; Xianlin Han; Joseph A Califano; Liang Shan; Xinbin Gu
Journal:  Oncotarget       Date:  2017-04-11

9.  Supercritical-Carbon Dioxide Fluid Extract from Chrysanthemum indicum Enhances Anti-Tumor Effect and Reduces Toxicity of Bleomycin in Tumor-Bearing Mice.

Authors:  Hong-Mei Yang; Chao-Yue Sun; Jia-Li Liang; Lie-Qiang Xu; Zhen-Biao Zhang; Dan-Dan Luo; Han-Bin Chen; Yong-Zhong Huang; Qi Wang; David Yue-Wei Lee; Jie Yuan; Yu-Cui Li
Journal:  Int J Mol Sci       Date:  2017-02-24       Impact factor: 5.923

10.  Identification of Small-Molecule Inhibitors of Neutral Ceramidase (nCDase) via Target-Based High-Throughput Screening.

Authors:  Yuka Otsuka; Michael V Airola; Yong-Mi Choi; Nicolas Coant; Justin Snider; Chris Cariello; Essa M Saied; Christoph Arenz; Thomas Bannister; Ron Rahaim; Yusuf A Hannun; Justin Shumate; Louis Scampavia; John D Haley; Timothy P Spicer
Journal:  SLAS Discov       Date:  2020-07-31       Impact factor: 3.341

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.